On adjusted median regression analysis (Supplementary Table 10), in comparison to healthy controls (Figure 4A and 4B), there was similar frequency of activated CD4+ T cells (P = .37) and CD8+ T cells (P = .67) post–BT infection in patients with HM. This evidence concerns the gene CD8A and infection.